Results 11 to 20 of about 58,970,387 (170)

Sobrevivência do câncer entre crianças e adolescentes em um serviço brasileiro de referência

Estrabão, 2023
Contexto: Poucos estudos foram encontrados que relatam sobrevida ao câncer em crianças e adolescentes no Brasil ao longo dos anos devido às informações limitadas. Nosso objetivo foi utilizar diferentes métodos de análise de tempo de sobrevida em crianças
J. Friestino, Denisa Mendonça, Pedro Oliveira, Luis Antunes, Rosemeire Olanda Ferraz, Priscila Francisco, Djalma Carvalho Moreira   +6 more
semanticscholar   +1 more source

Análisis de dos grupos etarios con Covid-19 para evaluar supervivencia utilizando las pruebas Kaplan-Meier

Revista médica (Colegio de Médicos y Cirujanos de Guatemala), 2021
Se pretende con este artículo, colaborar con el clínico del Instituto Guatemalteco de Seguridad Social (IGSS), para el estudio de sus casos en enfermedades crónicas como diabetes, hipertensión y enfermedades cardiovasculares, problemas renales, etc. pero
Edmundo Velásquez-García
semanticscholar   +1 more source

No margin for non-adherence: Probabilistic kaplan-meier modeling of imatinib non-adherence and treatment response in CML (ADAGIO study).

Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis, 2021
BACKGROUND Although adherence to imatinib is critical for attaining treatment responses in chronic myeloid leukemia, there is evidence of varying adherence among patients.
M. Obeng-Kusi, K. MacDonald, M. van Lierde, Christopher S Lee, S. De Geest, I. Abraham   +5 more
semanticscholar   +1 more source

Effectiveness and Safety of Edoxaban in the Routine Clinical Care of Atrial Fibrillation Patients in Brazil: Prospective 1-Year Follow-Up Study - EdoBRA. [PDF]

Arq Bras Cardiol
Resumo Fundamento A edoxabana é um anticoagulante oral que se mostrou segura e eficaz na prevenção de acidente vascular cerebral em pacientes com fibrilação atrial (FA).
Precoma DB, Silva RPD, Passos LCS, Hoffman Filho CR, Silveira FS, Vasconcelos JTM, Zimmermann SL, Herdy AH, Ritter A, Freitas-Alves D, Saraiva JFK.   +10 more
europepmc   +2 more sources

Kaplan-Meier survival estimates.

, 2022
Kaplan-Meier survival estimates.
Florian Hofer (7377338), Jonas Schreyögg (9711235), Tom Stargardt (5064095)   +2 more
core   +2 more sources

Kaplan-Meier survival analysis.

, 2022
a. Kaplan-Meier survival analysis of the “any time before” analysis. b. Kaplan-Meier survival analysis of the “within 72h” analysis.
Masamitsu Sanui (3452669), Junji Shiotsuka (4277068), Shigehiko Uchino (2305), Alan Kawarai Lefor (6593720), Tomoyuki Masuyama (12380784), Yusuke Sasabuchi (5052107)   +5 more
core   +1 more source

Kaplan-Meier seroprotection diagram.

, 2021
Kaplan-Meier seroprotection diagram.
Samsuridjal Djauzi (3840121), Alisa Nurul Muthia (11846344), Cissy Kartasasmita (5094791), Nuning Masjkuri (11846338), Mardiati Nadjib (4033538), Ummu Habibah (11846350), Rini Mulia Sari (6331079), Sukamto Koesnoe (11846335), Mondastri Korib (11846341), Novilia Sjafri Bachtiar (6331082), Julitasari Sundoro (10035770), Saskia Aziza Nursyirwan (11846353), Kristoforus Hendra Djaya (11846356), Asri Adisasmita (10924813), Virly Nanda Muzellina (11846347)   +14 more
core   +1 more source

Small-Vessel Coronary Disease and Drug-Coated Balloons: Time to Reconsider Our Strategy? [PDF]

Arq Bras Cardiol
meta-analysis cannot establish such a conclusion. Nevertheless, the PICCOLETO II trial— encompassing 232 patients and comparing PCB with everolimus-eluting stent—demonstrated significantly less late lumen loss with PCB, achieving both non-inferiority and
Prado GFA, Ribeiro HB.
europepmc   +2 more sources

Kaplan-Meier survival analysis.

, 2018
Kaplan-Meier survival analysis.
Anna Iglesias (105490), Angel Luis Martinez de Francisco (5533427), Israel Ortega (161084), Sara Pich (5533421), Monica Coll (672590), Gema Fernández-Fresnedo (5533424), Jesus Mates (672591), Eduardo Salas (168271), Manuel Arias (3715771), Paloma Barreda (5533418), Oscar Campuzano (105492), Carles Ferrer-Costa (10293), Catarina Allegue (672588), Emilio Rodrigo (3715780), Ramon Brugada (105500)   +14 more
core   +2 more sources

Kaplan-Meier survival curve.

, 2022
Percent survival is shown in this Kaplan-Meier survival curve.
Thomas Briese (67195), Todd M. Bell (12072418), Heather L. Esham (12072424), Paul Facemire (12072421), Lisa E. Hensley (7164947), W. Ian Lipkin (67196), Sara C. Johnston (10073925), Ginger C. Donnelly (12072427), Curtis Cline (12072415), Anna N. Honko (12072433), Joshua C. Johnson (12072430), Joshua D. Shamblin (9010217), Xiankun Zeng (623049)   +12 more
core   +1 more source